Lundbeckfonden

Lundbeckfonden operates as a Danish enterprise foundation, primarily dedicated to advancing biomedical sciences, with a significant focus on brain health research. It functions as a long-term, responsible investor in healthcare companies, holding substantial ownership in enterprises with potential for international leadership. The foundation's core activities involve both strategic investment and substantial philanthropic grant-making to foster scientific discovery.

The foundation was formally established in 1954 by Grete Lundbeck, a prominent businesswoman. Her initiative arose from the legacy of her late husband, Hans Lundbeck, who founded the pharmaceutical company H. Lundbeck A/S. Grete Lundbeck's vision was to secure the long-term future and independence of the pharmaceutical company while simultaneously creating a robust platform for supporting scientific research for the benefit of society.

Ultimately, Lundbeckfonden serves the broader scientific community, particularly researchers in biomedical fields, and aims to improve health outcomes for patients globally. Its overarching vision is to cultivate impactful ripple effects, translating scientific discoveries into practical applications that enhance human lives. The foundation consistently works towards expanding knowledge and innovation within the healthcare sector through its unique dual role as investor and grantor.